Nicotine therapeutic benefits: Difference between revisions
Jump to navigation
Jump to search
(formatting) |
(formatting) |
||
| Line 382: | Line 382: | ||
<br> | <br> | ||
= | ='''Brain Injury / Disease'''= <!--T:77--> | ||
===2004 [https://pubmed.ncbi.nlm.nih.gov/15681815/ Nicotinic receptor modulation for neuroprotection and enhancement of functional recovery following brain injury or disease]=== <!--T:78--> | ===2004 [https://pubmed.ncbi.nlm.nih.gov/15681815/ Nicotinic receptor modulation for neuroprotection and enhancement of functional recovery following brain injury or disease]=== <!--T:78--> | ||
| Line 393: | Line 392: | ||
*Acknowledgements: This work was supported by grants from the National Institutes of Health (NS42196 to J.R.P. and NS39828 to S.W.S.) and the Kentucky Tobacco Research and Development Center. We acknowledge the technical assistance of Melissa Yingling and Khaled Tanwir. | *Acknowledgements: This work was supported by grants from the National Institutes of Health (NS42196 to J.R.P. and NS39828 to S.W.S.) and the Kentucky Tobacco Research and Development Center. We acknowledge the technical assistance of Melissa Yingling and Khaled Tanwir. | ||
*KEYWORDS: nicotine; neurodegeneration; neuroprotection | *KEYWORDS: nicotine; neurodegeneration; neuroprotection | ||
<br> | |||
==Cancer / Cancer Treatments== <!--T:80--> | ==Cancer / Cancer Treatments== <!--T:80--> | ||